Clinical trials
Recruiting Observational Atherosclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
48 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2010 | 3 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 4 |
| 2022 | 1 |
| 2023 | 7 |
| 2024 | 8 |
| 2025 | 6 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 48 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 4 |
| Chinese University of Hong Kong | 3 |
| Novartis Pharmaceuticals | 2 |
| University Hospital, Grenoble | 2 |
| Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1 |
| Austral University, Argentina | 1 |
| Azienda Ospedaliero-Universitaria di Parma | 1 |
| Bangladesh University of Engineering and Technology | 1 |
| Brigham and Women's Hospital | 1 |
| Cambridge University Hospitals NHS Foundation Trust | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Atherosclerosis | 48 |
| Cardiovascular Diseases | 11 |
| Coronary Artery Disease | 10 |
| Stroke | 6 |
| Diabetes Mellitus, Type 2 | 4 |
| Hypertension | 4 |
| Ischemic Stroke | 4 |
| Myocardial Ischemia | 4 |
| Acute Coronary Syndrome | 3 |
| Cardiomyopathies | 3 |
Trials
Showing 1 to 25 of 48. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.